Skip to main content

Site notifications

MIDAZOLAM MEDICIANZ (Medsurge Pharma Pty Ltd)

Product name
MIDAZOLAM MEDICIANZ
Date registered
Evaluation commenced
Decision date
Approval time
130 (255 working days)
Active ingredients
midazolam
Registration type
New generic medicine
Indication

IV as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;

IV for induction of anaesthesia, preliminary to administration of other anaesthetic agents. With the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.

IV for sedation in intensive care units; intermittent administration or continuous infusion.

IM for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.